Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2

Sponsor Class

OTHER 4NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2

Conditions

Lymphoma 25Leukemia 25Precursor Cell Lymphoblastic Leukemia-Lymphoma 18Lymphoma, Large B-Cell, Diffuse 16Lymphoma, Follicular 16Breast Neoplasms 16Leukemia, Myeloid, Acute 15Lymphoma, Non-Hodgkin 14Lymphoma, Mantle-Cell 13Lymphoma, Large-Cell, Immunoblastic 13Burkitt Lymphoma 13Neoplasms, Plasma Cell 12Multiple Myeloma 12Leukemia, Lymphocytic, Chronic, B-Cell 12Lymphoma, B-Cell, Marginal Zone 10Leukemia, Myeloid, Chronic-Phase 10Neuroblastoma 9Myelodysplastic Syndromes 9Hodgkin Disease 9Congenital Abnormalities 9Leukemia, Myelomonocytic, Chronic 8Leukemia, Myeloid, Accelerated Phase 8Myeloproliferative Disorders 7Central Nervous System Neoplasms 7Blast Crisis 7Waldenstrom Macroglobulinemia 6Primary Myelofibrosis 6Recurrence 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5Polycythemia Vera 5

Interventions

X-Rays 5Phantoms, Imaging 5Magnetic Resonance Spectroscopy 5Cyclophosphamide 5cixutumumab 4Vincristine 4Specimen Handling 4Sirolimus 4Nuclear Medicine Department, Hospital 4Doxorubicin 4temsirolimus 3Temozolomide 3Irinotecan 3Etoposide 3Biopsy 3ulixertinib 2tipifarnib 2tazemetostat 2selpercatinib 2palbociclib 2olaparib 2larotrectinib 2ivosidenib 2ensartinib 2Vinorelbine 2Vemurafenib 2Radiotherapy 2Peripheral Blood Stem Cell Transplantation 2LY3023414 2Ifosfamide 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NIH × Rhabdomyosarcoma × Peripheral Blood Stem Cell Transplantation × Clear all
NCT00043979 2017-05-31

Stem Cell Transplantation in Patients With High-Risk and Recurrent Pediatric Sarcomas

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
60 enrolled 31 charts
Sarcoma

Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Desmoplastic Small Round Cell Tumor

NCT00001566 2012-06-15

A Pilot Study of Autologous T-Cell Transplantation With Vaccine Driven Expansion of Anti-Tumor Effectors After Cytoreductive Therapy in Metastatic Pediatric Sarcomas

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
42 enrolled 16 charts
Sarcoma

Rhabdomyosarcoma, Sarcoma, Ewing

Data powered by HemOnc (CC BY 4.0) Colophon âš¡